Position in SLS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,300,168
+$4,853,650 QoQ
Shares Held
359,090
+203.2% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#25
of 192 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $414,894,447 across 381 Biotechnology names. SLS ranks #13 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,522 | $19,031,687 | |
| 2 | ASND |
Ascendis Pharma A/S
|
43,289 | $11,546,042 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
116,611 | $8,685,187 | |
| 4 | MRNA |
Moderna, Inc.
|
123,281 | $8,633,368 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
30,496 | $7,348,621 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
61,501 | $7,052,319 | |
| 7 | CYTK |
Cytokinetics Inc
|
80,743 | $6,878,496 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
81,923 | $6,682,459 |
All Filings in SLS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,300,168 | 359,090 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $446,518 | 118,440 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $168,411 | 76,900 | Shares | Defined | 2025-08-12 | |
| 2024-12-31 | $55,563 | 53,426 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $78,481 | 62,785 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $17,564 | 17,391 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $45,124 | 42,570 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $54,090 | 32,982 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $130,751 | 55,403 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||